Mediterranean Diet May Be Better Than Statins For Heart Disease

Mediterranean Diet’s Newest Benefit: Curbing Depression

Eating a Mediterranean-style diet — one that is rich in fish, olive oil, nuts and vegetables — may be more effective at cutting the risk of death in people with cardiovascular disease than statins — and without the side effects.

Findings, presented at the European Society of Cardiology Congress in Rome, showed that people with cardiovascular disease that followed the diet were 37% less likely to have an early death compared to those not adhering to the diet.

In comparison, a 2003 analysis of 200,000 people with cardiovascular disease found taking statins alone reduced the likelihood of early death by just 18%.

Researchers looked at 1,200 Italians with a history of heart disease over 7 years. Those who closely followed a Mediterranean diet were less likely to be to be among the 208 people who died during the course of the study.

Although researchers conceded that the study was observational in nature —  meaning they couldn’t say for sure that it was the diet that caused the death risk reduction — they say the results warrant further investigation.

“These results prompt us to investigate the mechanism(s) through which the Mediterranean diet may protect against death,” says Giovanni de Gaetano, PhD, of the IRCCS Neuromed Institute in Pozzilli, Italy.

However, it may not be wise to cut statins altogether as they may further boost a decline in early death risk when taken in combination with the Mediterranean diet, some experts warn.

One of the most common side effects reported with statin use are muscle aches and pain. However, some studies have indicated there may be other side effects linked with statins, including diabetes and cognitive effects.

Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.

Did you find this article helpful?

Latest News

Breaking News – EpiPen Malfunction

Breaking News – EpiPen Malfunction

Just released from the FDA – Pfizer has informed the FDA that they are aware of several continuing problems that people are having using the EpiPen (epinephrine) and EpiPen Jr (epinephrine) auto-injectors and generic versions. Some of the problems are from user error and some from EpiPen malfunction. Here are…

ACE Inhibitors in the Time of Coronavirus

ACE Inhibitors in the Time of Coronavirus

Are you worried about ACE inhibitors and coronavirus? You may be hearing that one of the entry methods for the coronavirus in humans is by attaching to the ACE-2 enzyme. This has raised alarms among those with heart disease who use ACE inhibitors (with names ending in -pril, such as…

  • Advertisement